Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes
Lung adenocarcinoma (LUAD) is the main histological type of lung cancer with an unfavorable survival rate. Metastasis is the leading LUAD-related death with Epithelial-Mesenchymal Transition (EMT) playing an essential role. The anticancer efficacies of the active ingredients in Chonglou have been wi...
Main Authors: | Fulai Zhao, Peng Zhao, Junli Chang, Xingyuan Sun, Xiaoping Ma, Binhao Shi, Mengchen Yin, Yongjun Wang, Yanping Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1112671/full |
Similar Items
-
Mechanism research of chonglou as a pain killer by network pharmacology
by: Yu-Tong Liu, et al.
Published: (2021-01-01) -
Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis
by: Fulai Zhao, et al.
Published: (2022-07-01) -
A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma
by: Binhao Shi, et al.
Published: (2023-06-01) -
Polyphyllin VI screened from Chonglou by cell membrane immobilized chromatography relieves inflammatory pain by inhibiting inflammation and normalizing the expression of P2X3 purinoceptor
by: Zhenhui Luo, et al.
Published: (2023-02-01) -
Intratibial osteosarcoma growth and pulmonary metastasis inhibition by HIPPO signaling pathway-induced photodynamic therapy
by: Wenyi Wang, et al.
Published: (2023-09-01)